Related Experiment Video

Updated: Oct 14, 2025

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
11:35

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants

Published on: May 4, 2018

8.3K

The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update

Dan Reynolds1, Marin Kollef2

  • 1Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, USA.

Drugs
|November 7, 2021
PubMed

Insights

Pseudomonas aeruginosa, a Gram-negative bacterium, causes severe nosocomial infections and exhibits rising antimicrobial resistance. Management strategies include prompt antimicrobial therapy and newer antibiotics for multi-drug resistant strains.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Pseudomonas aeruginosa is a Gram-negative pathogen causing significant nosocomial infections, including pneumonia.
  • It poses a particular threat to immunocompromised individuals and those with cystic fibrosis.
  • Increasing trends in antimicrobial resistance, especially multi-drug resistance (MDR), are a growing concern.

Purpose of the Study:

  • To review the clinical significance of Pseudomonas aeruginosa infections.
  • To highlight the challenges posed by antimicrobial resistance in P. aeruginosa.
  • To discuss current and emerging management strategies for P. aeruginosa infections.

Main Methods:

  • Literature review of epidemiological studies on P. aeruginosa resistance trends.
  • Analysis of P. aeruginosa virulence factors contributing to severe infections.
  • Overview of clinical management guidelines and therapeutic options.

Main Results:

  • P. aeruginosa possesses multiple virulence mechanisms, including toxins, quorum sensing, and biofilm formation.
  • Multi-drug resistant (MDR) P. aeruginosa isolates are increasingly prevalent.
  • Newer anti-pseudomonal antibiotics are crucial for managing MDR infections.

Conclusions:

  • Effective management of P. aeruginosa infections requires a multi-faceted approach.
  • Antimicrobial stewardship and the judicious use of novel agents are essential.
  • Continued surveillance of resistance patterns is critical for guiding treatment decisions.

More Related Videos

Modeling Persistent Pseudomonas aeruginosa Infection in Wounded Zebrafish Larvae06:04

Modeling Persistent Pseudomonas aeruginosa Infection in Wounded Zebrafish Larvae

Published on: June 13, 2025

235
Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

33.4K

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
497
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
135
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.7K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
391
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
947
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
73